drug eluting stent - UpToDate
WEBDrug-eluting stents (DES) were developed to reduce the high rate of restenosis and subsequent need for repeat revascularization …. Coronary artery stent thrombosis: Incidence and risk factors. …bare metal and the first generation drug-eluting stents ( SES and PES) at up to five years .
Intracoronary stents: Stent types - UpToDate
WEBFor most patients undergoing percutaneous coronary intervention with stenting, current-generation drug-eluting stents (DES) are preferred to bare metal stents d
Percutaneous coronary intervention with intracoronary stents ... - UpToDate
WEBJan 9, 2023 · Learn about the use of stents and drug-eluting stents (DES) in percutaneous coronary intervention (PCI), a minimally invasive procedure to improve blood flow in the coronary arteries. This article covers stent types, deployment, medication use, and …
Drug-Eluting Stents: Technical and Clinical Progress
WEBFeb 9, 2023 · Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous revascularization procedures.
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
WEBSep 29, 2016 · We compared the effectiveness of contemporary drug-eluting stents versus bare-metal stents in a broad group of patients that included more than 72% of those who were eligible, and the...
Drug-eluting coronary stents: insights from preclinical and
WEBJul 25, 2019 · Implantation of drug-eluting stents (DES) is the main treatment strategy for patients with coronary artery disease. Stent design, stent material, strut thickness and vessel-wall coverage all...
Drug-Eluting Coronary-Artery Stents | New England Journal of …
WEBJan 17, 2013 · Drug-eluting stents provide site-specific, controlled release of antiproliferative agents targeting the suppression of neointimal hyperplasia.
Short- and Long-Term Outcomes With Drug-Eluting and Bare …
WEBMay 14, 2012 · Drug-eluting stents (DES) are widely used for percutaneous coronary intervention in patients with coronary artery disease. These stents have the advantage of reducing the incidence of in-stent restenosis compared with bare-metal stents (BMS).
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for ...
WEBOct 18, 2022 · With 775 patients, EMINENT (Trial Comparing Eluvia Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery) is the largest randomized trial of drug-eluting stent treatment for symptomatic femoropopliteal arterial disease to report patency results to date.
Long-Term Outcomes With Drug-Eluting Stents: Beyond Stent …
WEBApproximately one-half million percutaneous coronary interventions are performed in the United States every year ( 1 ), with the vast majority utilizing drug-eluting stents (DES), which are now preferred over bare-metal stents (BMS) due to the marked decrease in restenosis ( 2, 3 ).
Skip to content